Navigation Links
Lilly Receives Award From National Medical Association
Date:7/27/2009

INDIANAPOLIS, July 27 /PRNewswire-FirstCall/ -- Eli Lilly and Company (NYSE: LLY) was given the Corporate Circle Partners award by the National Medical Association (NMA) at their 113th annual conference and scientific assembly over the weekend in Las Vegas.

Lilly has developed a long-standing, productive partnership with the NMA to advance specific issues facing patients and to address healthcare disparities.

"We can't do this alone," said Mohammad N. Akhter, M.D., MPH, executive director, National Medical Association. "As strong as the NMA and Lilly are separately, together we have greater impact in this country for the betterment of all of us."

Signature NMA programs such as the Global Health Initiative and policy shaping consensus panel are examples of the collaboration with Lilly. In addition, the NMA continues to actively participate in a Lilly diabetes initiative that serves to empower African Americans to overcome key barriers to success in living with diabetes, the Fearless African-Americans Connected and Empowered (F.A.C.E.) campaign.

Further, in an effort to increase the diversity of its clinical trials, Lilly also utilizes physicians involved in the NMA's Project Impact as clinical trial investigators. Project Impact encourages greater participation of African Americans in all aspects of biomedical research and clinical trials, including supporting African-American physicians in the process.

"We are honored and humbled by this noteworthy acknowledgment," said Jack Harris, M.D., vice president of the U.S. medical division at Lilly. "Lilly shares a common interest with the NMA - to come together to share knowledge that goes beyond medicine to improve individual patient outcomes."

National Medical Association

Founded in 1895, the National Medical Association is the nation's oldest and largest medical association representing the interests of more than 30,000 African-American physicians and their patients. The NMA has repeatedly advocated for policies that would assure equitable and quality health care for all people.

About Lilly

Lilly, a leading innovation-driven corporation, is developing a growing portfolio of pharmaceutical products by applying the latest research from its own worldwide laboratories and from collaborations with eminent scientific organizations. Headquartered in Indianapolis, Ind., Lilly provides answers - through medicines and information - for some of the world's most urgent medical needs. Additional information about Lilly is available at www.lilly.com.

(Logo: http://www.newscom.com/cgi-bin/prnh/20031219/LLYLOGO)

C-LLY


'/>"/>
SOURCE Eli Lilly and Company
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. FDA Approves Expanded Use of Lillys FORTEO(R) [teriparatide (rDNA origin) injection] to Treat Glucocorticoid-Induced Osteoporosis
2. Lilly Reports Solid Second-Quarter 2009 Results, Raises EPS Guidance
3. Daiichi Sankyo and Lilly Receive U.S. FDA Approval for Effient(TM)
4. Lilly Celebrates Its 35th Year as a Supporter of the Indiana Black Expo
5. Lilly Sets Date and Conference Call for Second-Quarter 2009 Financial Results Announcement
6. Lilly Receives Fourth FDA Approval for ALIMTA(R) (pemetrexed for injection)
7. Lilly Declares Third-Quarter Dividend
8. New Therapies, Including Novel Biologic Agents from Elan/Wyeth and Eli Lilly, Will Drive Robust 11 Percent Annual Growth In the Alzheimers Disease Market
9. Eli Lilly and Company Announces New Drug Discovery Initiative
10. NAACP & Nine Class Reps File Motion for Class Certification Against Eli Lilly in Pervasive Discrimination Case
11. ICON Selected to Manage Lilly Clinical Trial Site Set Up and Monitoring in Europe
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/11/2016)... ... 11, 2016 , ... According to an article published February 1st ... dietary supplement, is being recalled due to the discovery that it contains dangerous adulterants. ... a single supplement on the market proven to help people safety lose excess weight, ...
(Date:2/11/2016)... ... 11, 2016 , ... Dr. Sadati’s recent feature in Allure ... with performing procedures, the magazine also highlights that Dr. Sadati has pioneered new ... the most common procedures he performs is his natural facelift. “As people age, ...
(Date:2/11/2016)... ... 11, 2016 , ... The president released a FY 2017 budget request on ... more of the cost burden to military beneficiaries. , MOAA’s president, retired Air ... budget as including limited quantifiable benefit fixes mixed with numerous beneficiary fee hikes. , ...
(Date:2/11/2016)... Irving, Texas (PRWEB) , ... February 11, 2016 ... ... for plastic surgery, dermatology and women’s health, is pleased to announce the promotions ... Practice Development Partners sales team, Steve Catone to executive vice president of North ...
(Date:2/11/2016)... ... February 11, 2016 , ... The Commission for ... the Board of Commissioners. Individuals interested in volunteer board service are encouraged to ... clinical practice settings and across allied health to contribute to its mission and ...
Breaking Medicine News(10 mins):
(Date:2/11/2016)... Scientists from Silicon Biosystems Menarini today ... door to genetic analysis of previously preserved tumor ... isolate with 100 percent purity. Utilizing the com­pany,s ... various stages of development, the researchers were able ... are clinically relevant, and may change the way ...
(Date:2/11/2016)... 11, 2016  AcelRx Pharmaceuticals, Inc. (NASDAQ: ACRX ... made at the 38th annual John A. Boswick ... which is being held February 14-18, 2016 in ... latest advancements in wound healing, burn care, and infection ... Australian-New Zealand Burns Association, Academy of Physicians in Wound ...
(Date:2/11/2016)... 2016  Ampio Pharmaceuticals, Inc. (NYSE MKT: AMPE) announced ... a Controlled Equity Offering SM Sales Agreement with ... Macaluso , Chairman and CEO, stated "During our most ... currently raising money and that we have enough money ... still complete all of our current objectives and nothing ...
Breaking Medicine Technology: